TEM
TEM
Indices, commodities, movers, heatmap, and top stories. No login required.
TEM
TEM NASDAQ
Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI: Less Risky Than When I Said Buy
Tempus Expands Strategic Collaboration with Bristol Myers Squibb
Pathos AI Announces Strategic Collaborations with Bristol Myers Squibb and Tempus AI to Advance AI-Driven Drug Development Beginning with Alzheimer's Disease and Other Neurological Conditions
Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Capital Returns
Operating & Net Margin (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.